By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Corbus Pharmaceuticals, Inc.  

100 River Ridge Drive

Norwood  Massachusetts  02062   U.S.A.
Phone: 1-617-963-0100 Fax: 1-617-663-6085


Company News
Corbus' Investigational Drug Resunab Granted Fast Track Status By The U.S. FDA For The Treatment Of Systemic Sclerosis 8/19/2015 11:37:36 AM
Vertex (VRTX)'s Success Spurs Startups Corbus and Pulmatrix to Enter Cystic Fibrosis Market 8/18/2015 6:21:45 AM
Corbus Reports 2015 Second Quarter Financial Results And Provides Business Update 8/13/2015 10:48:16 AM
Corbus To Present At The Canaccord Genuity Growth Conference On August 13, 2015 8/7/2015 10:43:54 AM
Corbus Announces Call Notice For Exercise Of Warrants 7/29/2015 12:04:54 PM
Corbus Announces Dosing Of First Patient In Phase II Clinical Trial Of Resunab For The Treatment Of Dermatomyositis 7/13/2015 10:12:33 AM
Corbus To Present At The JMP Securities Life Sciences Conference On June 23, 2015 6/18/2015 12:31:36 PM
Corbus Announces Inclusion In Russell MicroCap Index 6/16/2015 11:13:14 AM
Corbus Announces FDA Orphan Drug Designation For Resunab For The Treatment Of Systemic Sclerosis (Scleroderma) 6/12/2015 11:11:32 AM
Corbus Expands Clinical Development Of Resunab With A Phase 2 Trial For The Treatment Of Rare Disease Dermatomyositis 6/8/2015 10:46:23 AM